Arthritis Flashcards
Factors influencing management of RA
Level of disease - early use of DMARDs, DMARDs vs symptomatic relief
Stage of therapy
Regulatory restrictions
Patient preference
Symptomatic management of RA
Paracetamol
NSAIDs - in early mx or acute flare; selective (celecoxib) or non-selective (ibuprofen); bridges to DMARDs
Opioids - weak (codeine, tramadol) or strong (morphine, pethidine)
Glucocorticosteroids - anti-inflammatory and immunosuppressive effect; decrease inflammatory cytokines
Intra-articular steroids - methylprednisolone, betamethasone. Indicated when only a few joints are involved
DMARDs - arrest or slow progression of bone and cartilage destruction
Side effects of glucocorticosteroids
Occur with prolonged use of high doses
Can lead to cushings
Cause DM and HPT
Psychological: sleep disturbances, mood changes, psychosis
MSK: osteoporosis, myopathy, bone necrosis
Side effects of intra-articulate steroids
Crystal arthropathy
Skin atrophy
Pigment changes
Limited to 4 per year
Examples of DMARDs and duration of therapy
Methotrexate, chloroquine, sulfasalazine
Takes between 6/52 and 6/12 to see result therefore therapy must be continued up until then
Features of osteoarthritis
Advanced age
Different joint profile - cervical NS lumbar spine, 1st CMJ, DIP joint, hip, knee
Stiffness pattern
Exam: crepitus, bony enlargement, decreased ROM, malalignment, tenderness
Synovial fluid less active
Radiological features present
Pattern of presentation
Management of osteoarthritis
Non-drug measures: A. Physic B. Weight loss C. Braces and insoles D. Exercise E. Assistive devices F. Surgery
Drug measures: A. Paracetamol B. NSAIDs - avoid LT when possible C. Weak opioids D. Adjuvants (amitriptyline) E. Intra-articular steroids - when effusions or signs of inflammation
3 phases of gout
Acute gout
Inter critical period
Chronic tophaceous gout
Features of acute gout
Painful inflamed single joint Maximal pain between 12-24 hours Synovial fluid with - bifringent Hyperuricaemia may be absent Complete resolution of symptoms between attacks
Long term complications of gout
Urate crystal stones
Renal impairment
Management of acute gout
Treat the acute attack
Anti-inflammatories: NSAIDs, colchicine, corticosteroids
Management of inter critical and chronic gout
Objectives: prevent further attacks, prevent complications
Non-pharm mx: diet
Pharm mx:
A. Decrease uric acid production - xanthine oxidase inhibitors (allopurinol)
B. Improve uric acid excretion - probenecid
Methotrexate MOA
Methotrexate metabolized to polyglutamate (active)
Together inhibit key enzymes -> interferes with metabolic processes (carbon metabolism, purine synthesis and pyramidine synthesis) -> alters intracellular nucleotide pools and increases adenosine release -> antirheumatic effect
Methotrexate contraindications
Pre-existing blood dyscrasias Renal or hepatic disease Previous or existing herpes or varicella infections Serous effusions Pregnancy Lactation
Side effects of methotrexate
BM suppression
Mucosal ulceration
Hepatotoxicity
Nephropathy
Hyperuricaemia
Derm - alopecia, rash, pigmentation, urticaria
Other - headache, drowsiness, malaise, fatigue, blurred vision